Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Dupuis, Nina ^a,b   Mazarati, Andrey ^c   Desnous, Béatrice ^a,b,d   Chhor, Vibol ^a,b   Fleiss, Bobbi ^a,b   Le Charpentier, Tifenn ^a,b   Lebon, Sophie ^a,b   Csaba, Zsolt ^a,b   Gressens, Pierre ^a,b,d   Dournaud, Pascal ^a,b   Auvin, Stéphane ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Encephalitis; Epileptogenesis; Kindling; Microglia; Minocycline; Toll like receptor; Virus

Indexed keywords

INTERLEUKIN 1BETA; MINOCYCLINE; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CYTOKINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MATURATION; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPILEPTOGENESIS; GLIA CELL; HIPPOCAMPUS; KINDLING; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; PERITONEUM MACROPHAGE; RAT; VIRUS ENCEPHALITIS; AGE; ANIMAL; BRAIN; CELL CULTURE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; ENCEPHALITIS; EPILEPSY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MACROPHAGE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; VIROLOGY; WISTAR RAT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; ANTIVIRAL AGENTS; BRAIN; CELLS, CULTURED; CYTOKINES; ENCEPHALITIS; ENCEPHALITIS, VIRAL; EPILEPSY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MACROPHAGES; MALE; MICROGLIA; MINOCYCLINE; POLY I-C; RATS; RATS, WISTAR; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 85003680949     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0773-6     Document Type: Article

References (49)

1. Getts DR, Balcar VJ, Matsumoto I, Muller M, King NJ. Viruses and the immune system: their roles in seizure cascade development. J Neurochem. 2008;104:1167-76.
2. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia. 2008;49 Suppl 6:13-8.
3. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407-10.
4. Rocca WA, Sharbrough FW, Hauser WA, Annegers JF, Schoenberg BS. Risk factors for complex partial seizures: a population-based case-control study. Ann Neurol. 1987;21:22-31.
5. Whitley RJ. Viral encephalitis. N Engl J Med. 1990;323:242-50.
6. Davison KL, Crowcroft NS, Ramsay ME, Brown DW, Andrews NJ. Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis. 2003;9:234-40.
7. Nicolosi A, Hauser WA, Beghi E, Kurland LT. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950-1981. J Infect Dis. 1986;154:399-408.
8. Cusick MF, Libbey JE, Patel DC, Doty DJ, Fujinami RS. Infiltrating macrophages are key to the development of seizures following virus infection. J Virol. 2013;87:1849-60.
9. Kirkman NJ, Libbey JE, Wilcox KS, White HS, Fujinami RS. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia. 2010;51:454-64.
10. Stewart KA, Wilcox KS, Fujinami RS, White HS. Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice. J Neuropathol Exp Neurol. 2010;69:1210-9.
11. Stringer J. Models available for infection-induced seizures. In: Pitkänen AS PA, Moshé SL, editors. Models of Seizures and Epilepsy. Burlington: Elsevier Academic Press; 2006. p. 521-6.
12. Libbey JE, Fujinami RS. Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Futur Virol. 2011;6:1339-50.
13. Kaushik DK, Gupta M, Basu A. Microglial response to viral challenges: every silver lining comes with a cloud. Front Biosci (Landmark Ed). 2011;16:2187-205.
14. Jensen S, Thomsen AR. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol. 2012;86:2900-10.
15. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732-8.
16. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, Rao G, Sun R, Haberland M, Modlin R, Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 2002;17:251-63.
17. Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handb Clin Neurol. 2012;107:163-75.
18. Kwon YS, Pineda E, Auvin S, Shin D, Mazarati A, Sankar R. Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J Neuroinflammation. 2013;10:30.
19. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis. 2008;31:327-33.
20. Town T, Jeng D, Alexopoulou L, Tan J, Flavell RA. Microglia recognize double-stranded RNA via TLR3. J Immunol. 2006;176:3804-12.
21. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 2001;21:2580-8.
22. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001;166:7527-33.
23. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A. 1999;96:13496-500.
24. Scholz S, Sela E, Blaha L, Braunbeck T, Galay-Burgos M, Garcia-Franco M, Guinea J, Kluver N, Schirmer K, Tanneberger K, et al. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment. Regul Toxicol Pharmacol. 2013;67:506-30.
25. Chhor V, Le Charpentier T, Lebon S, Ore MV, Celador IL, Josserand J, Degos V, Jacotot E, Hagberg H, Savman K, et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun. 2013;32:70-85.
26. Thery C, Chamak B, Mallat M. Cytotoxic effect of brain macrophages on developing. Eur J Neurosc. 1991;3:1155-64.
27. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. In: Coligan JE et al., editors. Current protocols in immunology, Chapter 14:Unit 14 11. 2008.
28. Mazarati A, Shin D, Auvin S, Sankar R. Age-dependent effects of topiramate on the acquisition and the retention of rapid kindling. Epilepsia. 2007;48:765-73.
29. Mazarati A, Wu J, Shin D, Kwon YS, Sankar R. Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study. Epilepsia. 2008;49:1777-86.
30. Sankar R, Auvin S, Kwon YS, Pineda E, Shin D, Mazarati A. Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling. Epilepsia. 2010;51:39-42.
31. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173:3916-24.
32. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol. 2011;85:6913-22.
33. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis. 2009;36:343-51.
34. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19:5054-65.
35. Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152-5.
36. Heida JG, Pittman QJ. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia. 2005;46:1906-13.
37. Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69:16-24.
38. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics. 2011;8:304-15.
39. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;29:142-60.
40. Garrido-Mesa N, Zarzuelo A, Galvez J. What is behind the non-antibiotic properties of minocycline? Pharmacol Res. 2013;67:18-30.
41. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem. 2000;275:31199-203.
42. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem. 2005;94:819-27.
43. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A. 2004;101:3071-6.
44. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke. 2006;37:1087-93.
45. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation. 2008;5:15.
46. Abraham J, Fox PD, Condello C, Bartolini A, Koh S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis. 2012;46:425-30.
47. Beheshti Nasr SM, Moghimi A, Mohammad-Zadeh M, Shamsizadeh A, Noorbakhsh SM. The effect of minocycline on seizures induced by amygdala kindling in rats. Seizure. 2013;22:670-4.
48. Wang DD, Englot DJ, Garcia PA, Lawton MT, Young WL. Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav. 2012;24:314-8.
49. Arnoux I, Hoshiko M, Diez AS, Audinat E. Paradoxical effects of minocycline in the developing mouse somatosensory Cortex. Glia. 2014;62:399-410.